Axogen Prices $208.7M Underwritten Public Offering Of 4.91M Shares At $42.50 Per Share
Axogen, Inc. ("Axogen" or the "Company") (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced the
Axogen raised about $209 million by selling new shares to investors at $42.50 each. When a company sells new shares, it means more ownership pieces exist, which can affect how much each piece is worth over time.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.